Thursday, August 5, 2004
All in the DNA? The GENECARD Study
By Pat French
Having a family member with coronary artery disease (CAD), especially
when the disease occurs early, has always been a risk factor for
CAD for other family members. How much of this risk relates to shared
genetic factors is unknown, but a recent Duke study has begun to
address this question.
The GENe identification in Early-onset Coronary ARtery Disease
(GENECARD) study was led by Dr. Elizabeth Hauser of the Duke Center
for Human Genetics and included the DCRI's Dr. Christopher Granger
and Dr. William Kraus. The study examined the genetic makeup of
1168 people from 438 families, including 493 pairs of siblings who
developed CAD before age 51 (for men) or age 56 (for women). The
results appear in the September issue
of the American Journal of Human Genetics.
The researchers divided the participants into 3 subgroups: 1) those
with acute coronary syndrome (ACS, unstable angina or heart attack)
in at least 2 siblings, 2) those with lipid abnormalities —high
triglyceride level and low HDL cholesterol level —in any member
of the nuclear family, and 3) those with no Type 2 diabetes in any
family member with CAD. They then analyzed the genetic profiles
of the participants for 395 regional genetic markers.
Across all 3 subgroups, regions on chromosome 1 (1q25) and chromosome
3 (3q13) were associated with a higher risk of CAD. In the subgroup
with ACS, regions on chromosomes 1q25 and 3q13 (ACS) were associated
with CAD, as were regions on chromosome 7p14 for the group with
abnormal lipid levels and chromosome 19p13 for the group without
diabetes.
This study, sponsored by the National Institutes of Health (NIH),
is one of the largest analyses of genetics in CAD. As such, it offers
a springboard for future analysis of candidate genes. A better understanding
of the relation between genetic makeup and CAD occurrence could
eventually drive the development of preventive agents for patients
at risk for CAD and therapies for those who already have the disease.
|